MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsMediumPositive
Announced Wed, 18 Mar · 18:14 IST

Aditya Ramniwas Dhoot has submitted the Exchange a copy of Disclosure pursuant to Regulations 31(1) and 31(2) of the SEBI (SAST) Regulations, 2011.by the promoters/promoter group to the stock Exchanges for release of pledge shares.

Pledge ReleasedOwnership Changes View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹30.98
prior close
₹30.98
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-0.2+0.0+0.3-1.0-5.7-5.5-3.8-8.1-8.0-2.8-5.4-3.3-2.5
Up moveDown movePending
AI summary

Promoter Aditya Ramniwas Dhoot has disclosed a release of 89,000 pledged shares of Mangalam Drugs and Organics Limited, representing about 0.56% of the company's total share capital. The release was carried out on 16 March 2026 and reported to the stock exchanges on 18 March 2026 under SEBI (SAST) Regulations 2011. The pledged shares were held as security for a loan from M/s Famy Care Private Limited. After this release, the promoter's encumbered holdings are reduced, while his total shareholding in the company remains unchanged.

Likely market impact

This is a positive signal for the stock — the promoter has freed up shares that were previously locked as collateral, which reduces financial pressure on the promoter group and lowers the risk of forced selling. However, given the small size (0.56% of capital), the direct impact on the share price is likely limited.